by PEAK Medicals | 6 November 2024
UPCOMING Join us forour roundtable in||latest advances in||your questions on||new therapies for||practice changes in||your patient cases in Antibody Drug Conjugates Giuseppe Banna Portsmouth Hospitals NHS Trust, UK Alessandra Curioni Cantonal Hospital Fribourg,...
by PEAK Medicals | 12 June 2024
Lung Cancer (ASCO 2024) Welcome & introduction by host Alfredo Addeo WHAT’S NEW IN TARGETED THERAPIES FOR NSCLC? XIUNING LE LATEST INSIGHTS IN ADCS FOR LUNG CANCER LIZZA HENDRIKS NEW ADVANCES IN IMMUNOTHERAPIES FOR LUNG CANCER ALFREDO ADDEO  } 1 h 32 min Get Your...
by PEAK Medicals | 30 April 2024
HER2 in Lung, GYNE & GI Cancers Welcome & introduction by host Ilaria Colombo Clinical implications of HER2 in gastrointestinal cancers Florian Lordick Treatment considerations for HER2-positive lung cancer Maximilian Hochmair Latest treatment updates in...
by PEAK Medicals | 6 February 2024
Biomarkers in GI & Lung The Significance of Biomarkers in GI Oncology for My Therapy Decision Sara De Dosso Biomarkers in GI Oncology: The Tests We Perform in Gastric and GEJ Today Rupert Langer Current Standards in in Lung Cancer Therapy: Which Biomarkers We...
by PEAK Medicals | 24 January 2024
Early NSCLC Welcome & introduction by host Isabelle Opitz Doing more with less: state of the art in tissue acquisition Carolin Steinack Current standards for pathology reporting in lung cancer Lukas Bubendorf Recent advances in thoracic surgery in lung cancer...
